# Spero Therapeutics, Inc.: Form DEF 14A, filed Sep 1, 2023

- Company: [Spero Therapeutics, Inc.](/companies/spro.md) (CIK 1701108)
- Form: DEF 14A
- Filed: 2023-09-01
- Accepted by EDGAR: Sep 1, 2023, 16:08 ET
- Period: 2023-10-05
- Accession: 0001193125-23-227642
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1701108/000119312523227642/d502179ddef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1701108/000119312523227642/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1701108/000119312523227642/d502179ddef14a.htm

Filed Sep 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001193125-23-227642. Last ingested by Listed: Nov 13, 2026, 16:27 ET. No prices; not investment advice.
